Pittsburgh Compound B is under investigation in clinical trial NCT01723553 (Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.